Literature DB >> 14691185

Histological findings in experimental macular surgery with indocyanine green.

Salvatore Grisanti1, Peter Szurman, Faik Gelisken, Sabin Aisenbrey, Jolanta Oficjalska-Mlynczak, Karl Ulrich Bartz-Schmidt.   

Abstract

PURPOSE: To analyze the effect of different concentrations and application intervals of indocyanine green (ICG) on the retina in an experimental setting of macular surgery.
METHODS: Twenty-one porcine eyes were used within 5 hours after enucleation. The eyes were hemisected and the vitreous removed. Different doses of ICG (up to 1 mg) were applied over the trephined macula, and the remainder of the eyecup was filled with a balanced salt solution (BSS). Both the ICG solution and the BSS were drained after 30 or 60 seconds and the complete eyecup irrigated and filled with fresh BSS. The posterior pole was then illuminated with a standard surgical light pipe and light source at maximum power for 3 minutes. Both the ICG-treated retina and the nontreated surrounding retina were processed for histology.
RESULTS: Exposure of the retina at different concentrations of ICG either for 30 or 60 seconds, followed by illumination, caused no histologically detectable damage compared with the controls. No microarchitectural disorganization or cellular disruption was detected. The vitreoretinal interface seemed unaffected.
CONCLUSIONS: Previously described severe damage to the inner retina of human donor eyes could not be found with even higher doses of ICG in this porcine model. Although differences within the species may contribute to these contradictory results, it is conceivable that the postmortem time and the vitality of the tissue influence the outcome in this ex vivo system.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14691185     DOI: 10.1167/iovs.03-0797

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  14 in total

Review 1.  [Macular hole. Survey and relevant surgical concepts].

Authors:  S Dithmar
Journal:  Ophthalmologe       Date:  2005-02       Impact factor: 1.059

2.  Indocyanine green accused.

Authors:  T L Jackson
Journal:  Br J Ophthalmol       Date:  2005-04       Impact factor: 4.638

3.  Chromovitrectomy: a new field in vitreoretinal surgery.

Authors:  Eduardo B Rodrigues; Carsten H Meyer; Peter Kroll
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-12-10       Impact factor: 3.117

4.  Let green lead not astray.

Authors:  J Sebag
Journal:  Br J Ophthalmol       Date:  2005-07       Impact factor: 4.638

5.  Which colour suits the vitreoretinal surgeon?

Authors:  Nanny Collaer; Peter Stalmans
Journal:  Br J Ophthalmol       Date:  2007-09       Impact factor: 4.638

6.  Macular function and morphology after peeling of idiopathic epiretinal membrane with and without the assistance of indocyanine green.

Authors:  J Hillenkamp; P Saikia; F Gora; H G Sachs; C P Lohmann; J Roider; W Bäumler; V-P Gabel
Journal:  Br J Ophthalmol       Date:  2005-04       Impact factor: 4.638

7.  Toxic effects of indocyanine green, infracyanine green, and trypan blue on the human retinal pigmented epithelium.

Authors:  L Kodjikian; T Richter; M Halberstadt; F Beby; F Flueckiger; M Boehnke; J G Garweg
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-04-15       Impact factor: 3.117

8.  In vivo biocompatibility of a new cyanine dye for ILM peeling.

Authors:  S Thaler; C Haritoglou; F Schuettauf; T Choragiewicz; C A May; F Gekeler; M D Fischer; H Langhals; A Schatz
Journal:  Eye (Lond)       Date:  2014-12-19       Impact factor: 3.775

9.  Involvement of illumination in indocyanine green toxicity after its washout in the ex vivo rat retina.

Authors:  Kazuhiro Tokuda; Charles F Zorumski; Yukitoshi Izumi
Journal:  Retina       Date:  2009-03       Impact factor: 4.256

10.  Histopathological analysis in experimental macular surgery with trypan blue.

Authors:  S Grisanti; P Szurman; O Tatar; F Gelisken; S Aisenbrey; J Oficjalska-Mlynczak; R Kaczmarek; K U Bartz-Schmidt
Journal:  Br J Ophthalmol       Date:  2004-09       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.